Clinical trial
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients…
NCT00003582 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00003582 |
|---|---|
| Title | Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer |
| Official title | Phase I/II Study to Evaluate Combined Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) and Amifostine (WR 2721, Ethyol) in Stage III and IV Inoperable Head and Neck Carcinomas |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma of Unknown Primary, Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | amifostine trihydrate, cisplatin, fluorouracil, paclitaxel, quality-of-life assessment, radiation therapy |
| Enrollment | 36 |
| Start date | May 1, 1988 |
| Primary completion | Dec 1, 1996 |
| Completion | Dec 1, 1996 |
| First posted | Feb 16, 2004 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: